Performance goals for the laboratory testing of antithrombin, protein C and protein S
- 1 January 2006
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 96 (11) , 584-589
- https://doi.org/10.1160/th06-07-0404
Abstract
To achieve a reliable analytical quality for both monitoring and diagnostic testing, laboratories need to fulfil the widely accepted analytical performance goals based on the biological variation of the analytes of testing. Not only is the short-term analytical performance, which regularly is assessed by internal quality control procedures, of importance, but also the long-term analytical performance. To assess the long-term analytical performance, data obtained from an external quality assessment programme can be used. In this study we have used the evaluation model designed by the ECAT Foundation for the assessment of the longterm analytical performance, including imprecision, bias and total analytical error. The model was applied to the data from 136 different laboratories for the assay of antithrombin (activity), protein C (activity and antigen) and protein S (activity, total and free antigen). The imprecision (median; range), reflected by the long-term analytical coefficient of variation (LCVA), was the lowest for antithrombin (7.6%; 2.6 – 43.8%) and the highest for protein S activity (17.2%; 4.3 – 88.6%). For bias and total error the same pattern was observed (antithrombin: 3.8%; 0.3 – 17.1% and 9.1%; 3.4 – 34.3%, respectively; protein S activity: 12.8%; 3.1 – 34.8% and 24.5%; 9.9 – 87.0%, respectively). For the majority of the laboratories (70 – 85%) the imprecision contributes considerably more to the total error than the bias. However the effect of the bias on the analytical quality is not negligible. Assays for antithrombin, protein C and protein S are mainly used for diagnostic testing. About 70 – 100% of the laboratories can fulfil the desirable performance goal for imprecision. The desirable performance goal for bias was reached by 50 – 95% of the laboratories. In all cases the highest numbers of laboratories fulfilling performance goals was obtained for the protein C variables. To improve the analytical quality in assays of antithrombin, protein C and protein S it is highly recommended that primarily imprecision (non-systematic failures) be suppressed. However the effect of the bias (systematic failures) on the analytical quality should not be neglected. A useful tool for determining the imprecision (LCVA) and bias is the long-term analytical performance evaluation model as used by the ECAT Foundation.Keywords
This publication has 10 references indexed in Scilit:
- A new quality control model using performance goals based on biological variation in External Quality Assurance Schemescclm, 2006
- External Quality Assessment and the Laboratory Diagnosis of ThrombophiliaSeminars in Thrombosis and Hemostasis, 2005
- Investigation and management of heritable thrombophiliaBritish Journal of Haematology, 2001
- General strategies to set quality specifications for reliability performance characteristicsScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Intra- and Interindividual Variability of Hemostatic Factors and Traditional Cardiovascular Risk Factors in a Three-year Follow-upThrombosis and Haemostasis, 1998
- Proposals for Setting Generally Applicable Quality Goals Solely Based on BiologyAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1997
- External quality assessment of thrombophilia testing in EuropeFibrinolysis, 1996
- Analytical Goals for InterferenceAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1991
- The Measurement of Haemostatic Factors in 16 European Laboratories: Quality Assessment for the Multicentre ECAT Angina Pectoris StudyThrombosis and Haemostasis, 1989
- Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical areaScandinavian Journal of Clinical and Laboratory Investigation, 1988